Engages the GIP receptor Targets glucose-dependent insulinotropic polypeptide a metabolic pathway most weight-management medications leave untouched
Brighten on Episode 69: women on semaglutide plus HRT lost significantly more weight at every timepoint than semaglutide alone, with the effect persisting after adjusting for age, baseline weight, diabetes, and support services
Participants using semaglutide have reported more significant weight loss compared to those on a placebo, with effects that are sustainable over the long term
While this supports weight loss, it can take a little time for your body to adjust
The endocrine system is similarly linked to things like mood and substance addiction,11 12 so DSIPs actions on the bodys hormones may be at least partly responsible for its potential effects in those areas as well
The upcoming SURMOUNT-MAINTAIN trial, expected to report results around mid-2026, will specifically compare the 5 mg maintenance dose against higher doses for weight maintenance after initial loss